KXI is a market-cap-weighted global fund tracking roughly 95–117 consumer staples names, while RSPS is a U.S.-only equal-weight fund holding about 37–39 names. KXI is dominated by mega-cap leaders such as WMT and COST , whereas RSPS caps each position near 3%, sharply reducing single-name concentration risk.
FXG and RSPS both deliver U.S. consumer staples exposure but use fundamentally different construction: FXG applies a multi-factor AlphaDEX screening model, while RSPS equal-weights the S&P 500 consumer staples universe. RSPS is the lower-cost fund, charging a 0.40% expense ratio versus 0.63% for FXG, a durable structural advantage for long-term holders.
Same sector, different sizing. Both funds invest in consumer staples, but PSCC targets small-capitalization names while RSPS holds large-cap S&P 500 staples companies on an equal-weight basis. Weighting drives concentration risk. PSCC's top 10 holdings represent a substantial share of assets, whereas RSPS's equal-weight design keeps any single stock near a roughly 3% weight, materially lowering single-name risk.
The central target of $35 is not an analyst consensus; because RSPS is an ETF, the figure is drawn from public discussion and technical milestones rather than individual sell-side price targets. At a recent price near $31.39, reaching $35 would require a rise of roughly 11%–12%, a move that would carry the fund back above its 52-week high and toward its 2022 peak.
IYK is a market-capitalization-weighted fund tilted toward mega-cap staples giants, while RSPS equal-weights every consumer staples member of the S&P 500 Index, reducing single-stock concentration. IYK blends roughly 11% healthcare and a small materials allocation into its staples core, whereas RSPS is a near-pure consumer staples portfolio.
FSTA tracks a market-capitalization-weighted index and concentrates heavily in mega-cap leaders, while RSPS equally weights every S&P 500 consumer staples constituent. FSTA carries a much lower expense ratio of 0.08%, versus 0.40% for RSPS , a meaningful cost advantage over long holding periods.
FTXG is a concentrated, sub-industry-focused fund targeting U.S. food and beverage companies, while RSPS offers broad, equal-weight exposure across the entire consumer staples sector. RSPS carries a lower expense ratio (0.40% vs. 0.60%) and substantially greater assets under management (AUM), giving it a structural cost and liquidity advantage.
All three funds target consumer staples, but their construction differs fundamentally: IYK is a U.S.-focused, market-cap-weighted fund; KXI is a global, market-cap-weighted fund; and RSPS is a U.S. equal-weighted fund. Expense ratios are clustered tightly between 0.38% and 0.40%, meaning cost is not the decisive factor in this comparison.
RSPS equal-weights roughly 37–39 S&P 500 consumer staples names, reducing mega-cap concentration; XLP uses market-cap weighting and is dominated by a handful of industry giants. Cost efficiency is not equal: XLP charges a 0.08% expense ratio versus 0.40% for RSPS, a meaningful long-term headwind for the equal-weight fund.
RSPS and VDC both target U.S. consumer staples but use opposite weighting approaches: RSPS equal-weights roughly 37 S&P 500 names, while VDC market-cap-weights more than 100 stocks. VDC is far cheaper at a 0.09% expense ratio versus 0.40% for RSPS, and it holds substantially more assets under management (AUM), giving it deeper liquidity.
RSPS tracks the S&P 500 Equal Weight Consumer Staples Index, holding roughly 37 large-cap U.S. consumer staples companies at near-equal weights rather than by market capitalization. The fund carries a net expense ratio of 0.40% and a low beta near 0.43, positioning it as a comparatively defensive, low-volatility sector vehicle.
FXG , KXI , and PBJ all occupy the consumer staples universe but follow sharply different strategies: smart-beta US exposure, broad global market-cap weighting, and a concentrated US food-and-beverage multifactor approach, respectively. KXI offers the deepest diversification with roughly 99 global holdings and the lowest expense ratio at 0.38%, compared with 0.63% for both FXG and PBJ.
All three funds provide consumer staples exposure, but they differ sharply in scope: GXPS and VDC are U.S.-focused, while KXI is a globally diversified portfolio. VDC is the clear cost leader at a 0.09% expense ratio, versus 0.15% for GXPS and 0.38% for KXI.
KXI tracks a broad global consumer staples index with roughly 100 holdings, while PBJ is a concentrated, multifactor equal-weighted portfolio of about 30 U.S. food and beverage stocks. KXI is the lower-cost option, with a net expense ratio of about 0.39% versus roughly 0.61% for PBJ.
All three funds are passive, market-cap-weighted consumer staples ETFs, but they differ sharply in geographic scope: FSTA and XLP are U.S.-only, while KXI adds meaningful global exposure. Cost efficiency is a key differentiator: FSTA and XLP each charge a 0.08% expense ratio, while KXI carries a notably higher 0.38% fee.
KXI offers global consumer staples exposure (roughly 100 holdings across the U.S., U.K., Japan, and Europe), while VDC is a U.S.-only fund of about 105 stocks. Cost is the starkest structural divide: VDC charges a 0.09% expense ratio versus 0.38% for KXI, a meaningful long-term drag difference.
FXG is a U.S.-only, smart-beta consumer staples fund that uses a multi-factor "AlphaDEX" methodology, while KXI is a broad, market-cap-weighted global consumer staples portfolio. KXI holds roughly 100+ names across developed and emerging markets; FXG is far more concentrated at roughly 40 holdings with a notable mid-cap tilt.
GXPS and KXI both target the consumer staples sector, but GXPS is a concentrated, U.S.-only fund while KXI provides diversified exposure to roughly 95 global staples companies. GXPS charges a lower net expense ratio of 0.15%, compared with 0.38% for KXI, giving it a structural cost advantage.
KXI is a market-cap-weighted, globally diversified consumer staples fund, while RSPS is a U.S.-only, equal-weighted strategy with far fewer holdings. KXI holds roughly 92 companies across the U.S., Europe, and Asia; RSPS holds about 38 S&P 500 staples names, all based in the United States.
IYK is a U.S.-only consumer staples fund tracking the Russell 1000 Consumer Staples RIC 22.5/45 Capped Index, while KXI offers global staples exposure through the S&P Global 1200 Consumer Staples (Sector) Capped Index. Both funds carry a nearly identical expense ratio of approximately 0.38%, but KXI holds roughly twice as many securities, adding geographic diversification across developed markets such as the United Kingdom, Japan, and Switzerland.